Teladoc Health (NYSE:TDOC) was downgraded by stock analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a note issued to investors on Friday, MarketBeat reports. They currently have a $80.00 price target on the health services provider’s stock. Jefferies Financial Group’s price objective would suggest a potential downside of 0.04% from the stock’s current price.
Several other analysts have also recently commented on TDOC. Oppenheimer set a $83.00 target price on shares of Teladoc Health and gave the stock a “buy” rating in a research note on Friday, September 6th. Zacks Investment Research downgraded Teladoc Health from a “buy” rating to a “hold” rating and set a $89.00 price target for the company. in a report on Wednesday, November 27th. Piper Jaffray Companies set a $87.00 price target on Teladoc Health and gave the stock a “buy” rating in a research note on Friday, August 16th. JPMorgan Chase & Co. raised their price objective on Teladoc Health from $82.00 to $83.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Finally, SunTrust Banks reaffirmed a “hold” rating and issued a $80.00 price objective on shares of Teladoc Health in a research report on Monday, December 2nd. Five analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $80.73.
Teladoc Health stock opened at $80.03 on Friday. The stock has a market capitalization of $5.79 billion, a P/E ratio of -55.58 and a beta of 1.40. Teladoc Health has a 12-month low of $42.08 and a 12-month high of $86.30. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.55 and a quick ratio of 6.55. The firm’s 50-day moving average is $77.48 and its two-hundred day moving average is $67.56.
In other Teladoc Health news, SVP Andrew Turitz sold 9,158 shares of the company’s stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $62.27, for a total transaction of $570,268.66. Following the completion of the sale, the senior vice president now directly owns 6,827 shares in the company, valued at $425,117.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Lewis Levy sold 2,025 shares of the company’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $80.50, for a total value of $163,012.50. Following the sale, the insider now owns 5,655 shares of the company’s stock, valued at $455,227.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 77,932 shares of company stock worth $5,737,496. 3.14% of the stock is currently owned by insiders.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in TDOC. CNB Bank lifted its holdings in shares of Teladoc Health by 100.0% during the 3rd quarter. CNB Bank now owns 400 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 200 shares in the last quarter. Capital Investment Advisory Services LLC increased its holdings in Teladoc Health by 800.0% in the 3rd quarter. Capital Investment Advisory Services LLC now owns 450 shares of the health services provider’s stock valued at $30,000 after purchasing an additional 400 shares in the last quarter. Marshall Wace North America L.P. acquired a new stake in Teladoc Health in the 1st quarter valued at $35,000. Tradewinds Capital Management LLC increased its holdings in Teladoc Health by 186.0% in the 2nd quarter. Tradewinds Capital Management LLC now owns 615 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 400 shares in the last quarter. Finally, Quadrant Capital Group LLC raised its position in Teladoc Health by 32.4% in the third quarter. Quadrant Capital Group LLC now owns 621 shares of the health services provider’s stock valued at $41,000 after purchasing an additional 152 shares during the period.
Teladoc Health Company Profile
Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Featured Article: What is Compound Interest?
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.